Bavarian Nordic issues Financial Calendar for 2013
(Thomson Reuters ONE) -
KVISTGAARD, Denmark, August 31, 2012 - Bavarian Nordic A/S (OMX: BAVA) announced
today its financial calendar for the year 2013.
7 March 2013 2012 Annual Report
17 April 2013 Annual General Meeting
16 May 2013 First quarterly report (Q1) for the three-month period ended
31 March 2013
22 August 2013 Half-year report (Q2) for the six-month period ended 30 June
2013
14 November 2013 Third quarterly report (Q3) for the nine-month period ended 30
September 2013
Pursuant to Article 12 of the Articles of Association, shareholders who wish to
submit a request for proposals for consideration at the Annual General Meeting
must lodge this with the Company no later than Thursday, March 7, 2013.
Moreover, it should be noted that Bavarian Nordic in a period of two weeks
before planned publication of quarterly reports (silent periods), will not
comment specifically on developments or financial issues and expectations. The
dates for silent periods will be published on the company's website:
www.bavarian-nordic.com/investor.
Asger Aamund
Chairman of the Board
Contact
Anders Hedegaard, President & CEO. Phone +45 23 20 30 64
About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline targets cancer
and infectious diseases, and includes ten development programs. In oncology, the
company's lead program is PROSTVAC(®), a therapeutic vaccine candidate for
advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial
and is being developed under a collaboration agreement with the National Cancer
Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC(®) has been tested
in nearly 600 patients. In infectious diseases, the company's lead program is
IMVAMUNE(®), a third-generation smallpox vaccine candidate that is being
developed and supplied for emergency use to the U.S. Strategic National
Stockpile under a contract with the U.S. Government. For more information, visit
www.bavarian-nordic.com
Forward-looking statements
This announcement includes "forward-looking statements" that involve risks,
uncertainties and other factors, many of which are outside of our control that
could cause actual results to differ materially from the results discussed in
the forward-looking statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance and/or other
information that is not historical information. We undertake no obligation to
publicly update or revise forward-looking statements to reflect subsequent
events or circumstances after the date made, except as required by law.
201213uk:
http://hugin.info/100065/R/1637802/526696.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via Thomson Reuters ONE
[HUG#1637802]
Unternehmensinformation / Kurzprofil:
Datum: 31.08.2012 - 10:26 Uhr
Sprache: Deutsch
News-ID 179413
Anzahl Zeichen: 3821
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic issues Financial Calendar for 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
